instead, growth arrest was encountered. Already before transplantation, the child showed constant weight gain with increasing appetite, despite continuous tapering of the corticosteroid dosage, and body weight reached the 90th percentile. At the last visit (age of 14 years), he displayed hypergonadotropic hypogonadism, and no signs of puberty were present ( Figure 1a) .
Liver enzymes were found elevated and a liver biopsy showed discrete steatosis hepatis without any specific pathological finding. Dyslipidemia was diagnosed (serum cholesterol 290 mg/dl, triglycerides 480 mg/dl, Lp(a) 88.8 mg/dl). An intravenous glucose tolerance test was normal, glycosylated hemoglobin was 5.7 %, and fasting glucose levels were normal. A reduction of all immunoglobulin (Ig) isotypes was also observed (IgG, IgA, IgM).
From birth on, muscular weakness was present. Mental and motor development was retarded. At 4 years of age, the child was able to walk, but continued to speak only few words and showed behavioral abnormalities resembling autism. In contrast to the poor growth, the head circumference was 497th percentile. Eye examination and magnetic resonance imaging of the head remained without pathological findings.
At the age of 10 years, magnetic resonance imaging was performed, demonstrating small hyperechogenic kidneys with multiple small cortical cysts (Figure 1b) . Magnetic resonance imaging of the liver and the pancreas were normal, and no signs of cholangiodysplasia or hepatic cysts were present.
In order to verify the presence of disease-causing chromosomal rearrangements, the patient was tested by conventional cytogenetics, array-based comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH). Karyotyping of GTG-banded chromosomes from peripheral blood lymphocytes at 450 bands resolution was performed according to standard procedures and did not reveal any chromosomal abnormality (46, XY). Array CGH was carried out using a sub-megabase resolution tiling path bacterial artificial chromosome (BAC) array, consisting of the human 32k Re-Array set (DNA kindly provided by Pieter de Jong, http://bacpac.chori.org/pHumanMinSet.htm), 1-3 the 1 Mb Sanger Clone set (clones kindly provided by Nigel Carter, Wellcome Trust Sanger Centre, Hinxton, UK) 4 and 390 sub-telomeric clones (assembled by members of the COST B19 initiative: molecular cytogenetics of solid tumors). Detailed protocols are available at the following website (http://www.molgen.mpg.de/~abt_rop/molecular_ cytogenetics/ProtocolsEntry.html). Three times 300 ng of patient's DNA and pooled control DNA were labelled with Cy5 and Cy3, respectively, using the Bioprime CGH labelling kit (Invitrogen, Carlsbad, CA, USA). Images were scanned by means of an Axon 4100A and analyzed by GenePix Pro 6.0 software (Axon Instruments, Foster City, CA, USA). Further analysis and visualization of array CGH data was carried out using the software package CGHPRO. 5 No background subtraction was performed. Raw data were normalized by 'Subgrid LOWESS'. Copy number gains and losses were determined by a conservative log 2 ratio threshold of 0.3 and À0.3, respectively. Profile deviations consisting of three or more neighboring BAC clones were considered as genomic aberrations and evaluated by FISH, unless they coincided with a published polymorphism as listed in the Database of Genomic Variants, (http://projects.tcag.ca/ variation/; version 13 December 2005). For visualizing the content of low-copy repeats in the ratio plots (Figure 2 ), each BAC clone was classified into one out of seven categories and color-coded as described previously. For verification of array CGH results by FISH, BAC clones RP11-445F12 and RP11-115K3, mapping to chromosome 17q12, were obtained from the RZPD (Deutsches Resourcenzentrum fü r Genomforschung, Berlin, Germany) and were labelled with spectrum orange using nick translation. Cep17 (Vysis, Downers Grove, IL, USA), a spectrum green labelled probe targeting the centromere of chromosome 17, was used as control probe. Hybridizations were performed on metaphase spreads prepared from peripheral blood lymphocytes. Chromosomes were counterstained with 4,6-diamidino-2-phenylindole. As shown in Figure 3 , these experiments confirmed the deletion in the patient and showed normal two signals in both parents in all metaphases analyzed.
RENAL DIAGNOSIS
Cystic renal disease owing to a de novo 1. 4 Mb heterozygous deletion of 17q12 including the entire TCF2/HNF-1b gene locus. a b Figure 1 | Phenotype of the patient at the age of 13 years. (a) Truncal obesity, short neck, and large ears, and (b) magnetic resonance imaging of the abdomen using gadolinium as the contrast medium. Note the small, hyperechogenic kidneys containing multiple cortical small cysts (arrows). For visualizing the content of low-copy repeats in the ratio plots, each BAC clone was classified into one out of seven categories and color-coded as described previously. 7 The color code is given by the color bar to the right (e.g., red ¼ no low-copy repeats). Both, the accumulation of low-copy repeats and the presence of DNA copy number polymorphisms at the breakpoints, as shown by the level bars in the close-up, suggest that these sites are hot spots for chromosomal rearrangements. 
DISCUSSION
Congenital abnormalities of the kidney and the urogenital tract are among the most common disorders in childhood. Heterogeneous phenotypes, often complicated by a variety of additional clinical symptoms, have hindered the identification of candidate genes and their correlation to specific clinical features. Recently, it has been speculated that about 15 % of human genetic disorders are caused by submicroscopic genomic imbalances, 8 not detectable at the average resolution of 10 Mb as provided by conventional cytogenetics. Identification of such small aberrations would narrow down the chromosomal regions of interest and considerably reduce the number of candidate genes. Depending on the chromosomal region, genomic imbalances of this size may encompass 100 or more candidate genes. By means of array CGH, we have identified a 1.4 Mb deletion on chromosome region 17q12 in a patient suffering from unclassified kidney disease and multiple clinical and biochemical abnormalities. The heterozygous deleted region comprises 12 known genes and some of them have already been linked to clinical features that are present in our patient. One gene out of this list is transcription factor 2/hepatocyte nuclear factor-1b (TCF2/HNF-1b), which plays a role in tissue-specific gene expression, most prominently in the liver, kidney, and pancreas. Haploinsufficiency of TCF2/HNF-1b, either owing to mutations or deletions, has already been implicated in pancreatic atrophy with maturity onset of diabetes in the young (MODY5), abnormal levels of liver enzymes, urogenital abnormalities, including atresia of the vas deferens and azoospermia in the affected males, and, most important, a wide range of renal manifestations. [9] [10] [11] In contrast to autosomal-dominant or autosomal-recessive polycystic kidney disease, kidneys of patients carrying TCF2/HNF-1b mutations are usually not enlarged. In some cases, they have been described as 'hypoplastic' and, on ultrasound, they often appear hyperechogenic, and corticomedullary differentiation is poor, as it is the case in our patient. The cysts are located in the cortex, are multiple, and have a diameter less then 10 mm (microcysts). Histologically glomerular enlargement with and without glomerular cysts is present. The proximal tubular system is dilated. Upon electronmicroscopy, a slight thickening of the basal membrane can be encountered. Also cases of oligomeganephronia have been reported. The mesangium is typically without any pathological findings.
Interestingly, a rapid progression to end-stage renal disease in childhood, as seen in our patient, is unusual in carriers of TCF2/HNF-1b abnormalities.
9,12,13 Therefore, we speculate that the deletion of additional genes located in the 1.4 Mb region aggravated the renal phenotype. One such gene in the deleted interval is LHX1 (LIM homeobox 1; Table 1) , which, together with TCF2/HNF-1b and PAX8, represents one of the earliest regulators in the pronephric anlage. TCF2/ HNF-1b inhibits kidney formation and LIM1 acts nephrogenic. [14] [15] [16] However, as shown in Xenopus, this relationship is not purely antagonistic, because TCF2/HNF-1b can only rescue PAX8/LIM1-induced enlargement and ectopic tubule formation and cannot suppress thickening of tubules and cyst-like structures. 17 The deletion revealed here most likely emerged through non-allelic homologous recombination of the two breakpoint flanking low-copy repeats, a process typical for genomic disorders. Usually, chromosomal breakpoints in genomic disorders are recurrent. Therefore, the 14 patients previously reported by Ulinski et al., 9 with renal manifestations and deletions of TCF2/HNF-1b, which are overlapping with our aberration, may share the same chromosomal rearrangement; thus, these cases, as well as our patient, may establish a novel micro-deletion syndrome.
Genetic analysis will not only improve classification of renal disorders with complex phenotype, but genotype-phenotype comparisons between patients with the same genetic defect will also have therapeutic implications. Our patient does not suffer from diabetes yet, but, based on array CGH data, he is at high risk of developing diabetes in the course of disease progression, thus close monitoring of his glucose metabolism should be considered. These findings also point to the fact that the absence of a family history of renal cystic disease and diabetes does not preclude the presence of de novo mutations or deletions and that such patients should always be investigated for underlying genetic causes.
We conclude that array CGH is a powerful technique, which will assist in the classification of renal disorders and will have impact on therapy.
